Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Polycystic kidney disease physical examination

Introduction

Overview

Overview

Patients with polycystic kidney disease usually are in discomfort. Physical examination of patients with polycystic kidney disease is usually remarkable for hypertension, jaundice, pallor, icteric sclera, palpable nodular hepatomegaly, palpable flank mass.

Physical Examination

Physical Examination

Physical examination of patients with polycystic kidney disease is usually remarkable for hypertension, jaundice, pallor, icteric sclera, palpable nodular hepatomegaly, palpable flank mass.[1][2][3]

Appearance of the Patient

  • Patients with polycystic kidney disease usually are in discomfort

Vital Signs

Skin

HEENT

Neck

  • Neck examination of patients with polycystic kidney disease is usually normal

Lungs

  • Pulmonary examination of patients with polycystic kidney disease is usually normal

Heart

  • Cardiovascular examination of patients with polycystic kidney disease is usually normal

Abdomen

Back

Genitourinary

  • Genitourinary examination of patients with polycystic kidney disease is usually normal

Neuromuscular

  • Neuromuscular examination of patients with polycystic kidney disease is usually normal

Extremities

References

References

  1. ↑ Gabow PA (1993). “Autosomal dominant polycystic kidney disease”. N Engl J Med. 329 (5): 332–42. doi:10.1056/NEJM199307293290508. PMID 8321262.
  2. ↑ Torres VE, Harris PC, Pirson Y (2007). “Autosomal dominant polycystic kidney disease”. Lancet. 369 (9569): 1287–301. doi:10.1016/S0140-6736(07)60601-1. PMID 17434405.
  3. ↑ Baker A, King D, Marsh J, Makin A, Carr A, Davis C, Kirby C (October 2015). “Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians”. Clin Kidney J. 8 (5): 531–7. doi:10.1093/ckj/sfv060. PMC 4581379. PMID 26413277.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2], Serge Korjian,Yazan Daaboul